Thank you to all who attended our recent Global Health Research programme management shared learning event.
It was great to hear about your experiences – the challenges and successes – of managing GHR projects.
For anyone unable to join, watch the event: https://t.co/LwdlQRdWad
An international study involving hundreds of Dundee children has found that the most frequently prescribed medication for the treatment of ADHD in children and adolescents is safe to use long-term - read the full story: https://t.co/wh0dBchX8W
New at #ERS2022 results of the STAR-COVID trial presented by Hani Abo-Leyah and @MereteLong
Stabilised synthetic sulforaphane did not improve clinical outcomes in patients with COVID19 pneumonia
@UoDMedicine@TASC_TCTU
We’re offering #ResearchFunding to build the capacity and capability of #LiverDisease research through enduring multidisciplinary partnerships, networks and collaborations.
Find out more at our webinar on 27 June and apply for funding: https://t.co/yVmyYjOn8K
#ILC2022
An expert @UoDMedicine who led work to make Tayside the first region in the world to effectively eliminate Hepatitis C will spearhead a £2.2 million project to lead elimination efforts in one of the countries worst affected by the disease
https://t.co/CZa3uD2I0L
University of Dundee Professor, John Dillion, is being recognised by the Coalition for Global Hepatitis Elimination for his contributions to advancing hepatitis elimination in Scotland and making a global impact. @NHSTayside https://t.co/FJfnwJTYOW
TASC are seeking volunteers to join our Public Patient Involvement (PPI) groups to ensure the public has a voice in research.
We would like volunteers from as wide a background as possible and some who have had COVID-19.
For more information please visit https://t.co/WpfK6TTIMd
Latest from the STAR-COVID trial announced today.
Rapid enrolment past 50 patients randomized. Thanks @TASC_TCTU @EvgenPharma and funders @lifearc1
STAR-COVID is testing whether SFX-01 will improve outcomes in hospitalized patients with suspected COVID19
https://t.co/41Wn1zZw6S
NHS Tayside is the first region in the world to eliminate hepatitis C with its pioneering approach.
We are committed to the elimination of hepatitis C in Scotland by 2024, & we will work closely with @NHSTayside to replicate their achievement.
More➡️https://t.co/3wwv5bThp9
@SteveMc98031102@TASC_TCTU@ProfJohnDillon@NHSTayside Wholeheartedly agree. Great team to work with and fantastic leadership from John. Model for research and clinical practice working symbiotically to achieve goal.
@TASC_TCTU@ProfJohnDillon@NHSTayside Loved working on this project with Prof Dillon back when TCTU was getting established. Really pleased and proud to see his vision becoming a reality. A quiet and humble genius that man! He's a superb PI to have worked alongside.